首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1705695

吸入式一氧化氮市場：按產品類型、按應用、按強度、按最終用戶、按地區

Inhaled Nitric Oxide Market, By Product Type, By Application, By Strength, By End User, By Geography

出版日期: 2025年02月10日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球吸入式一氧化氮市場規模估計為 13.1 億美元，預計 2032 年將達到 22.1 億美元，2025 年至 2032 年的年複合成長率為 7.7%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	13.1億美元
效能數據	2020-2024/td>	預測期	2025-2032
預測期：2025-2032年複合年成長率：	7.70%	2032年價值預測	22.1億美元

數字。 2025年吸入式一氧化氮市場佔有率（按地區）

吸入性一氧化氮（iNO）是一種選擇性肺血管擴張劑，核准用於治療患有低氧血症性呼吸衰竭的新生兒和足月新生兒。 iNO透過擴張肺血管、改善通氣-灌注匹配和降低肺動脈高壓發揮作用。吸入時，iNO 會與肺部的氧氣和水迅速反應生成二氧化氮和硝酸鹽。由於這些分解產物不溶於脂，因此很少iNO進入血液，不會造成全身血管擴張。透過這種選擇性肺血管擴張，iNO 能夠顯著改善患有低氧血症性呼吸衰竭的新生兒的氧合，而不會加劇通氣灌注不匹配或引起全身性低血壓。

市場動態：

全球吸入性一氧化氮市場的成長是由早產和新生兒呼吸窘迫症候群發病率的上升所推動的。例如，根據世界衛生組織（WHO）2025年5月報告的數據，早產是五歲以下兒童死亡的主要原因。早產併發症將導致2020年約90萬名兒童死亡，其中75%可透過具成本效益的介入措施來預防。此外，吸入一氧化氮擴大被主要臨床實踐指南推薦作為新生兒低氧性呼吸衰竭的一線治療方法，加速了其應用。然而，iNO輸送系統和氣瓶的價格過高可能會抑制市場成長。同時，正在進行的關於 iNO 對成人急性呼吸窘迫症候群(ARDS) 等其他肺部疾病的有效性的研究為市場擴張提供了有利可圖的機會。

本研究的主要特點

本報告對全球吸入式一氧化氮市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2024 年。

它強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。

它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數，對全球吸入式一氧化氮市場的主要企業進行了概述。

研究中介紹的主要企業包括 Mallinckrodt plc、Linde PLC、Nippon Oxygen Holdings、SOL Group、Air Liquide SA、Air Water Inc.、Chemix Specialty Gases and Equipment、Vero Biotech LLC、四川薩爾曼化學產品有限公司、成都泰宇工業有限公司、Bellerophon Therapeutics Inc.、MJA.Fellernx. Plus Inc.、Beyond Air Inc.、Praxair Technology Inc.、Getinge Group 和 Circassia Pharmaceuticals。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員將透過用於分析全球吸入式一氧化氮市場的各種策略矩陣更輕鬆地做出決策。

Mallinckrodt plc
Linde PLC
Nippon Sanso Holdings Corporation
SOL Group
Air Liquide SA
Air Water Inc.
Chemix Specialty Gases and Equipment
Vero Biotech LLC
Sichuan Salman Chemical Products Co., Ltd.
Chengdu Taiyu Industrial Gases Co., Ltd.
Bellerophon Therapeutics Inc.
Merck KGaA
GE Healthcare
Mitsubishi Tanabe Pharma Corporation
Messer Group
Nu-Med Plus Inc.
Beyond Air Inc.
Praxair Technology Inc.
Getinge Group
Circassia Pharmaceuticals

第 10 章分析師建議

命運之輪
分析師觀點
一致的機會圖

第 11 章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI7478

Global Inhaled Nitric Oxide Market is estimated to be valued at USD 1.31 Bn in 2025 and is expected to reach USD 2.21 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 1.31 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.70%	2032 Value Projection:	USD 2.21 Bn

Figure. Inhaled Nitric Oxide Market Share (%), By Region 2025

Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator approved for treating term and near-term neonates with hypoxic respiratory failure. iNO works by dilating pulmonary vessels, improving ventilation-perfusion matching, and reducing pulmonary hypertension. Upon inhalation, iNO rapidly reacts with oxygen and water in the lungs to produce nitrogen dioxide and nitrate. As these breakdown products are not lipid soluble, iNO has very little ability to enter the bloodstream and cause systemic vasodilation. This selective pulmonary vasodilation allows iNO to significantly improve oxygenation without worsening ventilation/perfusion mismatching or causing systemic hypotension in neonates with hypoxic respiratory failure.

Market Dynamics:

The global inhaled nitric oxide market growth is driven by the rising incidence of preterm births and respiratory distress syndrome among neonates. For Instance, in May 2025, according to the data reported by World Health Organization, prematurity is the leading cause of death among children under 5 years of age. Preterm birth complications caused around 900,000 child deaths in 2020, with 75% preventable through cost-effective interventions; global preterm birth rates in 2020 ranged from 4-16%. Moreover, inhaled nitric oxide has been increasingly recommended as the first-line therapy for hypoxic respiratory failure in newborns by leading clinical practice guidelines, thereby fuelling its adoption. However, the market growth can be restrained by the exorbitant price of iNO delivery systems and cylinders. On the other hand, ongoing research on the efficacy of iNO in other lung conditions like acute respiratory distress syndrome (ARDS) in adults presents lucrative opportunities for market expansion.

Key features of the study:

This report provides in-depth analysis of the global inhaled nitric oxide market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global inhaled nitric oxide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Mallinckrodt plc, Linde PLC, Nippon Sanso Holdings Corporation, SOL Group, Air Liquide S.A., Air Water Inc., Chemix Specialty Gases and Equipment, Vero Biotech LLC, Sichuan Salman Chemical Products Co., Ltd., Chengdu Taiyu Industrial Gases Co., Ltd., Bellerophon Therapeutics Inc., Merck KGaA, GE Healthcare, Mitsubishi Tanabe Pharma Corporation, Messer Group, Nu-Med Plus Inc., Beyond Air Inc., Praxair Technology Inc., Getinge Group, and Circassia Pharmaceuticals.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global inhaled nitric oxide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhaled nitric oxide market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Inhaled Nitric Oxide Delivery Systems
- Consumables
- Nitric Oxide Cylinders
- Delivery Accessories
- Others
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Neonatal Respiratory Treatment
- Chronic Obstructive Pulmonary Disease (COPD)
- Acute Respiratory Distress Syndrome (ARDS)
- Tuberculosis Treatment
- Malaria Treatment
- Others
Strength Insights (Revenue, USD Bn, 2020 - 2032)
- 100 ppm
- 800 ppm
- Others
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Mallinckrodt plc
- Linde PLC
- Nippon Sanso Holdings Corporation
- SOL Group
- Air Liquide S.A.
- Air Water Inc.
- Chemix Specialty Gases and Equipment
- Vero Biotech LLC
- Sichuan Salman Chemical Products Co., Ltd.
- Chengdu Taiyu Industrial Gases Co., Ltd.
- Bellerophon Therapeutics Inc.
- Merck KGaA
- GE Healthcare
- Mitsubishi Tanabe Pharma Corporation
- Messer Group
- Nu-Med Plus Inc.
- Beyond Air Inc.
- Praxair Technology Inc.
- Getinge Group
- Circassia Pharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Inhaled Nitric Oxide Market, By Product Type
- Inhaled Nitric Oxide Market, By Application
- Inhaled Nitric Oxide Market, By Strength
- Inhaled Nitric Oxide Market, By End User
- Inhaled Nitric Oxide Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Inhaled Nitric Oxide Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Inhaled Nitric Oxide Delivery Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nitric Oxide Cylinders
Delivery Accessories
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Inhaled Nitric Oxide Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Neonatal Respiratory Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic Obstructive Pulmonary Disease (COPD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Acute Respiratory Distress Syndrome (ARDS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Tuberculosis Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Malaria Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Inhaled Nitric Oxide Market, By Strength, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
100 ppm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
800 ppm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Inhaled Nitric Oxide Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Inhaled Nitric Oxide Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Mallinckrodt plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Linde PLC
Nippon Sanso Holdings Corporation
SOL Group
Air Liquide S.A.
Air Water Inc.
Chemix Specialty Gases and Equipment
Vero Biotech LLC
Sichuan Salman Chemical Products Co., Ltd.
Chengdu Taiyu Industrial Gases Co., Ltd.
Bellerophon Therapeutics Inc.
Merck KGaA
GE Healthcare
Mitsubishi Tanabe Pharma Corporation
Messer Group
Nu-Med Plus Inc.
Beyond Air Inc.
Praxair Technology Inc.
Getinge Group
Circassia Pharmaceuticals